SIGNR3/CD209d Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-10192
Key Product Details
Species Reactivity
Mouse
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of mouse SIGNR3/CD209d (NP_570974.1). Peptide sequence DMHNEATWHWVDGSPLSPSFTRYWNRGEPNNVGDEDCAEFSGDGWNDLSC
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
22 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for SIGNR3/CD209d Antibody
Western Blot: SIGNR3/CD209d Antibody [NBP3-10192]
Western Blot: SIGNR3/CD209d Antibody [NBP3-10192] - Western blot analysis of SIGNR3/CD209d in Mouse SP2/0 Whole Cell lysates. Antibody dilution at 1ug/mlApplications for SIGNR3/CD209d Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: SIGNR3/CD209d
Long Name
DC-SIGN-related Protein 3
Alternate Names
CD209d
Gene Symbol
CD209
Additional SIGNR3/CD209d Products
Product Specific Notices for SIGNR3/CD209d Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...